PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsDiscoid lupus erythematosus
MeSH D008179 - discoid lupus erythematosus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008178:Cutaneous lupus erythematosus
0 Companies
0 Drugs
Success rate
D008179: 
Discoid lupus erythematosus
$
Success rate
D015435:Lupus erythematosus panniculitis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Bristol Myers SquibbThalidomide Thalidomide BMS (previously Thalidomide Celgene)  2008-04-16   
Thalidomide Thalomid 2023-12-09 1998-07-16   
LipomedThalidomide Thalidomide Lipomed  2022-09-19   
NATCO PharmaThalidomide Thalidomide  2023-04-27   
Clinical Trials
Historical Success Rate
Phase 1
33%
1/3
Phase 2
0%
0/8
Phase 3
100%
2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bristol Myers Squibb
Sanofi
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use